<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_NEU_China_A_Model skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:NEU China A/Model</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="igem_2018_team_menu displaying_menu"><A href="https://2018.igem.org/Team:NEU_China_A"><DIV class="menu_item direct_link">
				HOME
			</DIV></A><DIV class="menu_item">
			TEAM
		</DIV><DIV class="submenu"><A href="https://2018.igem.org/Team:NEU_China_A/Team"><DIV class="submenu_item">
					Team Members
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Collaborations"><DIV class="submenu_item">
					Collaborations
				</DIV></A></DIV><DIV class="menu_item">
			PROJECT
		</DIV><DIV class="submenu"><A href="https://2018.igem.org/Team:NEU_China_A/Description"><DIV class="submenu_item">
					Description
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Design"><DIV class="submenu_item">
					Design
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Experiments"><DIV class="submenu_item">
					Experiments
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Notebook"><DIV class="submenu_item">
					Notebook
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/InterLab"><DIV class="submenu_item">
					InterLab
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Model"><DIV class="submenu_item">
					Model
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Results"><DIV class="submenu_item">
					Results
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Demonstrate"><DIV class="submenu_item">
					Demonstrate
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Improve"><DIV class="submenu_item">
					Improve
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Attributions"><DIV class="submenu_item">
					Attributions 
				</DIV></A></DIV><DIV class="menu_item">
			PARTS
		</DIV><DIV class="submenu"><A href="https://2018.igem.org/Team:NEU_China_A/Parts"><DIV class="submenu_item">
					Parts Overview
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Basic_Part"><DIV class="submenu_item">
					Basic Parts
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Composite_Part"><DIV class="submenu_item">
					Composite Parts
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Part_Collection"><DIV class="submenu_item">
					Part Collection
				</DIV></A></DIV><A href="https://2018.igem.org/Team:NEU_China_A/Safety"><DIV class="menu_item direct_link">
				SAFETY
			</DIV></A><DIV class="menu_item"> 
			HUMAN PRACTICES 
		</DIV><DIV class="submenu"><A href="https://2018.igem.org/Team:NEU_China_A/Human_Practices"><DIV class="submenu_item">
					Human Practices
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Public_Engagement"><DIV class="submenu_item">
					Education &amp; Engagement
				</DIV></A></DIV><DIV class="menu_item"> 
			AWARDS
		</DIV><DIV class="submenu"><A href="https://2018.igem.org/Team:NEU_China_A/Applied_Design"><DIV class="submenu_item">
					Applied Design
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Entrepreneurship"><DIV class="submenu_item">
					Entrepreneurship
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Hardware"><DIV class="submenu_item">
					Hardware
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Measurement"><DIV class="submenu_item">
					Measurement
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Model"><DIV class="submenu_item">
					Model
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Plant"><DIV class="submenu_item">
					Plant
				</DIV></A><A href="https://2018.igem.org/Team:NEU_China_A/Software"><DIV class="submenu_item">
					Software
				</DIV></A></DIV><A href="https://igem.org/2018_Judging_Form?team=NEU_China_A"><DIV class="menu_item direct_link">
				JUDGING FORM ⇗ 
			</DIV></A></DIV><DIV class="igem_2018_team_content"><DIV class="igem_2018_team_column_wrapper"><HEADER class="navbar-fixed"><NAV class="blu nav-extended" style="margin-top:0"><DIV class="nav-wrapper"><A href="#" data-target="mobile-demo" class="sidenav-trigger"><I class="material-icons">menu</I></A><UL class="right hide-on-med-and-down"><LI><A data-target="project" class="dropdown-trigger" href="#!">
                        Project<I style="margin-left: 0" class="material-icons right">arrow_drop_down</I></A></LI><LI><A data-target="lab" class="dropdown-trigger" href="#!">
                        Lab<I style="margin-left: 0" class="material-icons right">arrow_drop_down</I></A></LI><LI><A data-target="parts" class="dropdown-trigger" href="#!">
                        Parts<I style="margin-left: 0" class="material-icons right">arrow_drop_down</I></A></LI><LI><A data-target="hp" class="dropdown-trigger" href="#!">
                        HP<I style="margin-left: 0" class="material-icons right">arrow_drop_down</I></A></LI><LI><A data-target="team" class="dropdown-trigger" href="#!">
                        Team<I style="margin-left: 0" class="material-icons right">arrow_drop_down</I></A></LI></UL></DIV><DIV class="nav-content"><UL class="tabs tabs-transparent"><LI class="tab"><A href="#Introduction-a">Introduction</A></LI><LI class="tab"><A href="#Assumption-a">Assumption</A></LI><LI class="tab"><A href="#Symbol Description-a">Symbol Description</A></LI><LI class="tab"><A href="#Fluorescence of GFP with Constant Inflammatory Signal-a">Fluorescence  intensityof GFP (1)</A></LI><LI class="tab"><A href="#Fluorescence of GFP with attenuated Inflammatory Signal-a">Fluorescence  intensity of GFP (2)</A></LI><LI class="tab"><A href="#Model solving-a">Model solving</A></LI></UL></DIV></NAV><UL class="sidenav" id="mobile-demo"><UL class="collapsible" style="margin-top: 16px"><LI><DIV class="collapsible-header"><I style="color: #03a9f4" class="material-icons">folder_open</I>Project</DIV><DIV class="collapsible-body"><DIV class="collection"><A href="https://2018.igem.org/Team:NEU_China_A/Introduction" class="collection-item">Introduction</A><A href="https://2018.igem.org/Team:NEU_China_A/Design" class="collection-item">Design</A><A href="https://2018.igem.org/Team:NEU_China_A/Model" class="collection-item">Model</A><A href="https://2018.igem.org/Team:NEU_China_A/Demonstrate" class="collection-item">Results &amp; Demonstrate</A><A href="https://2018.igem.org/Team:NEU_China_A/Interlab" class="collection-item">InterLab</A></DIV></DIV></LI><LI><DIV class="collapsible-header"><I style="color: #03a9f4" class="material-icons">place</I>Lab</DIV><DIV class="collapsible-body"><DIV class="collection"><A href="https://2018.igem.org/Team:NEU_China_A/Notebook" class="collection-item">Notebook</A><A href="https://2018.igem.org/Team:NEU_China_A/Protocols" class="collection-item">Protocols</A><A href="https://2018.igem.org/Team:NEU_China_A/Safety" class="collection-item">Safety</A></DIV></DIV></LI><LI><DIV class="collapsible-header"><I style="color: #03a9f4" class="material-icons">details</I>Parts</DIV><DIV class="collapsible-body"><DIV class="collection"><A href="https://2018.igem.org/Team:NEU_China_A/BasicAndCompositeParts" class="collection-item">Basic
                            And Composite Parts</A><A href="https://2018.igem.org/Team:NEU_China_A/Improve" class="collection-item">Improved
                            Biobricks</A></DIV></DIV></LI><LI><DIV class="collapsible-header"><I style="color: #03a9f4" class="material-icons">lightbulb_outline</I>HP</DIV><DIV class="collapsible-body"><DIV class="collection"><A href="https://2018.igem.org/Team:NEU_China_A/HumanPractices" class="collection-item">Human
                            Practices</A><A href="https://2018.igem.org/Team:NEU_China_A/Collaborations" class="collection-item">Collaborations</A><A href="https://2018.igem.org/Team:NEU_China_A/Engagement" class="collection-item">Engagement</A></DIV></DIV></LI><LI><DIV class="collapsible-header"><I style="color: #03a9f4" class="material-icons">people</I>Team</DIV><DIV class="collapsible-body"><DIV class="collection"><A href="https://2018.igem.org/Team:NEU_China_A/TeamMember" class="collection-item">Team Member</A><A href="https://2018.igem.org/Team:NEU_China_A/Attributions" class="collection-item">Attributions</A><A href="https://2018.igem.org/Team:NEU_China_A/Gallery" class="collection-item">Gallery</A></DIV></DIV></LI></UL></UL><UL id="project" class="dropdown-content"><LI><A href="https://2018.igem.org/Team:NEU_China_A/Introduction">Introduction</A></LI><LI><A href="https://2018.igem.org/Team:NEU_China_A/Design">Design</A></LI><LI><A href="https://2018.igem.org/Team:NEU_China_A/Model">Model</A></LI><LI><A href="https://2018.igem.org/Team:NEU_China_A/Demonstrate">Results &amp; Demonstrate</A></LI><LI><A href="https://2018.igem.org/Team:NEU_China_A/Interlab">Interlab</A></LI></UL><UL id="lab" class="dropdown-content"><LI><A href="https://2018.igem.org/Team:NEU_China_A/Notebook">Notebook</A></LI><LI><A href="https://2018.igem.org/Team:NEU_China_A/Protocols">Protocols</A></LI><LI><A href="https://2018.igem.org/Team:NEU_China_A/Safety">Safety</A></LI></UL><UL id="parts" class="dropdown-content"><LI><A href="https://2018.igem.org/Team:NEU_China_A/BasicAndCompositeParts">Basic And Composite Parts</A></LI><LI><A href="https://2018.igem.org/Team:NEU_China_A/Improve">Improved Biobricks</A></LI></UL><UL id="hp" class="dropdown-content"><LI><A href="https://2018.igem.org/Team:NEU_China_A/HumanPractices">Human Practices</A></LI><LI><A href="https://2018.igem.org/Team:NEU_China_A/Collaborations">Collaborations</A></LI><LI><A href="https://2018.igem.org/Team:NEU_China_A/Engagement">Engagement</A></LI></UL><UL id="team" class="dropdown-content"><LI><A href="https://2018.igem.org/Team:NEU_China_A/TeamMember">Team member</A></LI><LI><A href="https://2018.igem.org/Team:NEU_China_A/Attributions">Attributions</A></LI><LI><A href="https://2018.igem.org/Team:NEU_China_A/Gallery">Gallery</A></LI></UL></HEADER><DIV style="position:absolute;top: 20;width:100%"><DIV class="row "><H2 style="padding-left:200px; padding-top:calc(100vh - 250px)">Model</H2></DIV></DIV><DIV class="container" style="margin-top: 16vh; width: 100%;"><DIV class="row"><DIV class="col s12"><DIV class="card white" id="Introduction"><DIV class="card-content"><SPAN class="card-title light-blue-text" style="font-size:2.5em">Introduction</SPAN><P class="gray-text" style="font-size:1.5em">In the affected area of ​​patients with inflammatory bowel disease, the concentration of nitric oxide is significantly increased, so we chose it as the input signal of our anti-inflammatory device. However, the nitric oxide is very unstable, so we have introduced an amplifier which can converts unstable gas signals into stable intracellular signals for sustained high-level output. The amplifier is based on a positive feedback loop. Transcription activator B-A can self-drive in a manner independent of the input signal for a period of time after the signal is input, and the metabolic flow in this cycle can be transferred to the output circuit (Figure 1). </P><P class="gray-text" style="font-size:1.5em"><STRONG class="black-text">Figure 1. Schematic Design of the Synthetic amplifier</STRONG>
                        After the signal is input, the transcriptional activator B-A is generated, which includes a DNA binding domain and a transcriptional activation domain. On the one hand, B-A can activate the expression of the reporter gene, and on the other hand can activate the expression of B-A itself. The constitutively expressed Binder will compete with B-A to suppress the leakage of the device.
                    </P><P style="margin-top: 8px;font-size:1.5em">
                        In addition, when using an amplifier based on a positive feedback loop, we need to strictly limit its activation until the input signal is strong enough, which is beneficial to suppress leakage of the device. To this end, we introduce the concept of threshold, which is to achieve competition between B-A and B by constitutively expressing Binder with a certain intensity (Figure 1). In this way, the amplifier can only be effectively activated when the input signal is strong enough. We established a mathematical model to predict the performance of the amplifier under different restrictions.
                    </P></DIV></DIV></DIV></DIV><DIV class="row"><DIV class="col s12"><DIV class="card white"><DIV class="card-content" id="Assumption"><SPAN class="card-title light-blue-text" style="font-size:2.5em">Assumption</SPAN><P class="gray-text" style="font-size:1.5em">
                        (1) The sequence that B-A and B bind is the same. So, it can be considered that both are combined with the same substrate.
                    </P><P class="gray-text" style="font-size:1.5em">
                        (2) B-A and B have the same promotion or inhibition effect on the amplifier and output circuit.
                    </P></DIV></DIV></DIV></DIV><DIV class="row"><DIV class="col s12"><DIV class="card white" id="Symbol Description"><DIV class="card-content"><SPAN class="card-title light-blue-text" style="font-size:2.5em">Symbol Description</SPAN><P class="black-text"><STRONG>Table 1. The name and symbol of variable. Correction: X2 represents for the concentration of Binder-Activator and X3 represents for the concentration of Binder. </STRONG></P></DIV></DIV></DIV></DIV><DIV class="row"><DIV class="col s12"><DIV class="card white" id="Fluorescence of GFP with Constant Inflammatory Signal"><DIV class="card-content"><SPAN class="card-title light-blue-text" style="font-size:2.5em">
                    Fluorescence intensity of GFP with Constant Inflammatory Signal
                </SPAN><H5 class="black-text" style="font-size: 2em">1.Available when the bacterial resources are extremely rich</H5><P class="gray-text" style="font-size:1.5em">
                        Firstly, the amplifier we described in Figure 1 can be simplified to the Figure 2.
                    </P><P class="black-text"><STRONG>Figure 2. Simple circuit of the amplifier</STRONG></P><P class="gray-text" style="font-size:1.5em">
                        The concentration of the Binder-Activator expressed by the input circuit is
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>P</MI><MN>2</MN></MSUB><MO>(</MO><MSUB><MI>x</MI><MN>1</MN></MSUB><MO>)</MO></MROW></MATH>
                        when the inflammatory signal is at a concentration of
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>1</MN></MSUB></MROW></MATH>

                        per unit time. The amount of Binder-Activator or GFP expressed by the amplifier or output circuit is
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MTEXT>P</MTEXT><MO>(</MO><MSUB><MI>x</MI><MN>2</MN></MSUB><MTEXT>,</MTEXT><MSUB><MI>x</MI><MN>3</MN></MSUB><MO>)</MO></MROW></MATH>
                        for the Binder-Activator and Binder at a concentration of
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>2</MN></MSUB></MROW></MATH>
                        and
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>3</MN></MSUB></MROW></MATH>
                        , respectively.
                        When the amplifier is used, it can be seen from the Figure 2 that Binder-Activator (
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>2</MN></MSUB></MROW></MATH>
                        ) has two synthetic pathways, one is that the inflammatory signal (
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>1</MN></MSUB></MROW></MATH>
                        ) promotes the synthesis of the input circuit, and the other is that
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>2</MN></MSUB></MROW></MATH>
                        facilitates the synthesis of the amplifier by
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>3</MN></MSUB></MROW></MATH>
                        . So, we can get this equation:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(1)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        There is only one synthetic pathway of y
                        , that is,
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>2</MN></MSUB></MROW></MATH>
                        and
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>3</MN></MSUB></MROW></MATH>
                        work together with the output circuit to release y,
                        so it can be obtained by assumption 2:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(2)</P></DIV><H6>
                        Ⅰ.
                     <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>P</MI><MN>1</MN></MSUB><MO>(</MO><MSUB><MI>x</MI><MN>1</MN></MSUB><MO>)</MO></MROW></MATH>
                        expression solving
                    </H6><P class="gray-text" style="font-size:1.5em">
                        The gene (equivalent to the binding sequence of Binder-Activator) is abbreviated as G, various transcriptional activators are abbreviated as S, and various transcriptional repressors (e.g. Binder) are abbreviated as I. The binding of
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>1</MN></MSUB></MROW></MATH>
                        to the NorR (it means the NorR will bind NO to activate the promoter PnorV) of input circuit is a reversible reaction, so the binding reaction of
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>1</MN></MSUB></MROW></MATH>
                        to the input circuit can be expressed as:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(3)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        k1 and k2 are the reaction rate constants of the forward reaction and the reverse reaction, respectively.
                        Refer to the Michaelis-Menten equation, we do the following analysis: when the reaction reaches equilibrium, the concentration of SG does not change, that is, the rate of SG generation and decomposition is equal, then we can get the following equation:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(4)</P></DIV><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(5)</P></DIV><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(6)</P></DIV><P class="gray-text" style="font-size:1.5em">
In fact, the increased rate of transcription of a regulated gene depends on the proportion of transcriptional activators that bind to the gene, and the more transcriptional activators that bind to the gene, the more the rate of expression of the gene increases. The expression of conversion to mathematics is:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(7)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Suppose that when the substrate concentration is large enough,
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>P</MI><MN>1</MN></MSUB><MO>(</MO><MSUB><MI>x</MI><MN>1</MN></MSUB><MO>)</MO></MROW></MATH>
                        will take the maximum value, set to
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>P</MI><MN>1max</MN></MSUB></MROW></MATH>
                        , and [S] will also be much larger than [G], so we can get this:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(8)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Bring the formula (6), (8) into equation (7) to get the analytical expression of
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>P</MI><MN>1</MN></MSUB><MO>(</MO><MSUB><MI>x</MI><MN>1</MN></MSUB><MO>)</MO></MROW></MATH>
                        :
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(9)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Although the body's immune system can make timely adjustments to the inflammatory response,
                   <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>1</MN></MSUB></MROW></MATH>
                        is considered to be a fixed value in a sufficiently short period of time, and
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>P</MI><MN>1</MN></MSUB><MO>(</MO><MSUB><MI>x</MI><MN>1</MN></MSUB><MO>)</MO></MROW></MATH>
                        can also be considered as a constant that varies with
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>1</MN></MSUB></MROW></MATH>
                        , abbreviated as A. The calculations that follow are handled this way.
                    </P><H6>Ⅱ.
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MTEXT>P</MTEXT><MO>(</MO><MSUB><MI>x</MI><MN>2</MN></MSUB><MTEXT>,</MTEXT><MSUB><MI>x</MI><MN>3</MN></MSUB><MO>)</MO></MROW></MATH>
                        expression analysis
                    </H6><P class="gray-text" style="font-size:1.5em">
                        Since
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>2</MN></MSUB></MROW></MATH>
                        ,
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>3</MN></MSUB></MROW></MATH>
                        binds to the same site in the gene, the gene will be activated when
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>2</MN></MSUB></MROW></MATH>
                        binds it while being inhibited when
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>3</MN></MSUB></MROW></MATH>
                        binds it. This can be regarded as the competition between
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>2</MN></MSUB></MROW></MATH>
                        and
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>3</MN></MSUB></MROW></MATH>
                        . Similar to the analysis we used to solve the expression of , we can get:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(10)</P></DIV><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(11)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        In the reaction,
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>2</MN></MSUB></MROW></MATH>
                        represents the concentration of S, and
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>3</MN></MSUB></MROW></MATH>
                        represents the concentration of I. The increase of the transcription rate of the gene depends on the concentration of SG, that is, the amount of the transcriptional activator that binds to the gene, and the gene that binds to
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>3</MN></MSUB></MROW></MATH>
                        can no longer bind to
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>2</MN></MSUB></MROW></MATH>
                        , resulting in inhibition of transcription. So,
                        </P><P class="gray-text" style="font-size:1.5em">
                        Analogy to the analysis we used to solve the expression of
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>P</MI><MN>1</MN></MSUB><MO>(</MO><MSUB><MI>x</MI><MN>1</MN></MSUB><MO>)</MO></MROW></MATH>
                        , we list the following relationships:
                        When it reaches equilibrium:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(12)</P></DIV><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(13)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        From this we can get the following equation:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(14)</P></DIV><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(15)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Sort out the above two formulas to get:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(16)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        The same way we get:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(17)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        When [S] is large enough,
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MTEXT>P</MTEXT><MO>(</MO><MSUB><MI>x</MI><MN>2</MN></MSUB><MTEXT>,</MTEXT><MSUB><MI>x</MI><MN>3</MN></MSUB><MO>)</MO></MROW></MATH>
                        will take the maximum value and set it to .
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>P</MI><MN>2max</MN></MSUB></MROW></MATH>
                        [S] will also be much larger than [G] and another in the denominator, so there are:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(18)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Bringing Equations (16), (18) into Equation (17) yields:
     </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(19)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        So, we get the expression of
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MTEXT>P</MTEXT><MO>(</MO><MSUB><MI>x</MI><MN>2</MN></MSUB><MTEXT>,</MTEXT><MSUB><MI>x</MI><MN>3</MN></MSUB><MO>)</MO></MROW></MATH>
                        .
                        Because the role of
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>3</MN></MSUB></MROW></MATH>
                        in the system is to set a threshold for the amplification of
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>2</MN></MSUB></MROW></MATH>
                        , and is set to a constitutive expression,
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>3</MN></MSUB></MROW></MATH>
                        can be regarded as a fixed value of the regulation, and
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>3</MN></MSUB></MROW></MATH>
                        becomes another variable constant.
                    </P><H6>
                        III. Calculation of :
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>2</MN></MSUB></MROW></MATH></H6><P class="gray-text" style="font-size:1.5em">
                        From the analysis of Equation (1) and the above two steps, the relationship between
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>2</MN></MSUB></MROW></MATH>
                        and time after adding the amplifier can be obtained:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(20)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        The relationship between GFP fluorescence intensity and time:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(21)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        When the amplifier is not used, y is directly synthesized by the inflammatory signal (
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>1</MN></MSUB></MROW></MATH>
                        ), from which we can get:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(22)</P></DIV><H5 class="black-text" style="font-size: 2em">2. Available when the bacterial resources are restricted</H5><P class="gray-text" style="font-size:1.5em">
                        The resources in bacteria are actually limited. In addition to using resources to synthesize the GFP, bacteria also need resources to maintain their normal life activities. At this time, there is competition between the amplifier and the bacteria's own life activities. The eventual result is that after a limited amount of resources are exhausted, the bacteria die and the amplifier stops working. Therefore, the following bacterial resource attenuation model is established.
                        Assuming that the total amount of resources in the bacteria is q, then when the resources decays, the following formula holds:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(23)</P></DIV><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(24)</P></DIV><P class="gray-text" style="font-size:1.5em">               Among the above relationship, K is the total amount of initial resources before decay, and
                        
                        is the time constant of the decay process, we can get:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(25)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Solution:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(26)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Then, when there is no amplifier, the model is corrected to:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(27)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        When there is an amplifier, the model is corrected to:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(28)</P></DIV><SPAN class="card-title light-blue-text" style="font-size:2.5em" id="Fluorescence of GFP with attenuated Inflammatory Signal">
                    Fluorescence intensity of GFP with attenuated Inflammatory Signal
                    </SPAN><P class="gray-text" style="font-size:1.5em">
                        The above model consistently believes that the intensity of the inflammatory signal is constant. However, in the actual biological environment, the inflammatory signal will be attenuated to varying degrees with distance, time and drug release. Therefore, the attenuation model of the inflammatory signal intensity is first established as follows.
                    </P><P><STRONG>Figure 3. The effect of attenuated inflammatory signal intensity on GFP output when bacterial resources are limited with an amplifier</STRONG></P><P class="gra1y-text" style="font-size:1.5em">
                        It is easy to get the inflammatory signal intensity decay rate as follows:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(29)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Where
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>K</MI><MN>s</MN></MSUB></MROW></MATH>
                        is the intensity of the inflammatory signal at the initial moment and
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MTEXT>T</MTEXT></MROW></MATH>
                        is the time constant of the decay process of the inflammatory signal. Solution:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(30)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Then the amount
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>P</MI><MN>1</MN></MSUB><MO>(</MO><MSUB><MI>x</MI><MN>1</MN></MSUB><MO>)</MO></MROW></MATH>
                        of Binder-Activator expressed in the input circuit is as follows:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(31)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Considering the attenuation of inflammatory signals and the limitation of bacterial resources, when there is no amplifier, the model is corrected to:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(32)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Considering the attenuation of inflammatory signals and the limitation of bacterial resources, when adding an amplifier, the model is corrected to:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(33)</P></DIV></DIV></DIV></DIV></DIV><DIV class="row"><DIV class="col s12"><DIV class="card white" id="Model solving"><DIV class="card-content"><SPAN class="card-title light-blue-text" style="font-size:2.5em">Model solving</SPAN><H6 style="font-size:2em">1. Parameter assignment table</H6><P class="gray-text" style="font-size:1.5em">
                        By referring to some previous work, the parameters are as follows:
                    </P><P><STRONG>Table 2. Parameter assignment</STRONG></P><H6 style="font-size:2em">2. Model solving without amplifier</H6><P class="gray-text" style="font-size:1.5em">
                        Ⅰ. When the intensity of the inflammatory signal is constant and the bacterial resources are considered to be unlimited, record
                        
                        , then
                        
                        . So, the fluorescence intensity is:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(34)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        That is:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(35)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Ⅱ. When the intensity of the inflammatory signal is constant but the bacterial resources are limited, record
                        
                        . So, the fluorescence intensity is:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(36)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        That is:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(37)</P></DIV><P><STRONG>Figure 4. The effect of bacterial resources on the GFP output without amplifier</STRONG></P><P class="gray-text" style="font-size:1.5em">
                        III. When the inflammatory signal is attenuated, but the bacterial resources are considered to be unlimited, the output GFP is solved as:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(38)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        That is:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(39)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        IV. When the inflammatory signal is attenuated and the bacterial resources are considered to be limited, the GFP is solved as:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(40)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        That is:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(41)</P></DIV><P><STRONG>Figure 5. The effect of bacterial resources on the GFP output when inflammatory signal is attenuated without amplifier</STRONG></P><H6 style="font-size:2em">3. Model solving with amplifier</H6><P class="gray-text" style="font-size:1.5em">
                        Ⅰ. When the intensity of the inflammatory signal is constant and the bacterial resources are considered to be unlimited, record
                        
                        , then:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(42)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Using MATLAB to solve for
                        
                        , it is:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(43)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Let
                        <MATH xmlns="http://www.w3.org/1998/Math/MathML"><MROW><MSUB><MI>x</MI><MN>2</MN></MSUB><MO>=</MO><MTEXT>g</MTEXT><MO>(</MO><MTEXT>t</MTEXT><MO>)</MO></MROW></MATH>
                        , then we get:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(44)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Then we get GFP as:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(45)</P></DIV><P class="gray-text" style="font-size:1.5em">
                        Ⅱ. When the intensity of the inflammatory signal is constant but the bacterial resources are limited, record
                        
                        . So, the fluorescence intensity is:
                    </P><DIV style="display: flex; justify-content: center ;align-items: center"><P>......(46)</P></DIV><P><STRONG>Figure 6. The effect of bacterial resources on the GFP output with amplifier</STRONG></P><P><STRONG>Figure 7. GFP output curve considering bacterial resources limitations with amplifier</STRONG></P><P class="gray-text" style="font-size:1.5em">
                        III. When the inflammatory signal is attenuated and the bacterial resources are limited, the Runge-Kutta method is used to solve the differential equation and the GFP curve is obtained as follows. Compared with the GFP curve without amplifier, the addition of the amplifier has obvious effect.
                    </P><P><STRONG>Figure 8. GFP output curve considering inflammatory signal attenuation and bacterial resources limitation</STRONG></P><H6 style="font-size:2em">4. Analysis of the regulatory role of Thresholder</H6><P class="gray-text" style="font-size:1.5em">
                        When the intensity of the inflammatory signal is attenuated and the bacterial resources are limited, in order to avoid the leakage of the positive feedback loop, we set the threshold regulate component Binder, the concentration can be varied between 10 and 100 mM. The regulation curve is as follows.
                    </P><P><STRONG>Figure 9. Binder regulation curve considering inflammatory signal attenuation and bacterial resources limitation</STRONG></P><P class="gray-text" style="font-size:1.5em">
                        In conclusion, the introduction of Thresholder does have a regulatory effect on the output of GFP and is very obvious, which has a positive effect on suppressing the leakage of the positive feedback loop.
                    </P><P class="gray-text" style="font-size:1.5em">
Our established model is based on some assumptions and approximations and lacks the support of experimental data. But we believe that our work can provide a reference to other work that requires the use of a positive feedback loop and threshold. In addition, we will conduct experiments to test the validity of our model in the future.
                    </P><P class="gray-text" style="font-size:1.5em">
[1] Smole,A., Lainsˇcek,D., Bezeljak,U., Horvat,S. and Jerala,R. (2017) A synthetic mammalian therapeutic gene circuit for sensing and suppressing inflammation. Mol. Ther., 25, 102–119.
                    </P><P class="gray-text" style="font-size:1.5em">
[2] Michaelis L, Menten M L. Die kinetic der invertinwirkung. Biochem. Z. , 1913, 49: 334-336
                    </P><P class="gray-text" style="font-size:1.5em">
[3] Runge, Carl David Tolmé (1895), &quot;Über die numerische Auflösung von Differentialgleichungen&quot;, Mathematische Annalen, Springer, 46 (2): 167–178,
                    </P></DIV></DIV></DIV></DIV></DIV><FOOTER class="page-footer blu"><DIV class="row container"><DIV class="col s6"><DIV class="col s6">Contact us</DIV></DIV></DIV></FOOTER></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>